These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2388292)
1. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration. Schilsky RL; Ratain MJ J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects. Straw JA; Szapary D; Wynn WT Cancer Res; 1984 Jul; 44(7):3114-9. PubMed ID: 6609768 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion. Straw JA; Newman EM; Doroshow JH NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and in vitro studies of l-leucovorin. Comparison with the d and d,l-leucovorin. Zittoun J Ann Oncol; 1993; 4 Suppl 2():1-5. PubMed ID: 8353099 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing. Schilsky RL; Choi KE; Vokes EE; Guaspari A; Guarnieri C; Whaling S; Liebner MA Cancer; 1989 Mar; 63(6 Suppl):1018-21. PubMed ID: 2783878 [TBL] [Abstract][Full Text] [Related]
7. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma. Meropol NJ; Petrelli NJ; Rustum YM; Rodriguez-Bigas M; Blumenson LE; Frank C; Berghorn E; Creaven PJ Invest New Drugs; 1995; 13(2):149-55. PubMed ID: 8617578 [TBL] [Abstract][Full Text] [Related]
8. Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography. Choi KE; Schilsky RL Anal Biochem; 1988 Feb; 168(2):398-404. PubMed ID: 2834981 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion. Newman EM; Straw JA; Doroshow JH Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin). Straw JA; Newman EM Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829 [No Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of fluorouracil and folinic acid. Schalhorn A; Kühl M Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660 [TBL] [Abstract][Full Text] [Related]
12. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin. Rustum YM Cancer; 1989 Mar; 63(6 Suppl):1013-7. PubMed ID: 2783877 [TBL] [Abstract][Full Text] [Related]
13. Bioactivity of orally administered unnatural isomers, [6R]-5-formyltetrahydrofolate and [6S]-5,10-methenyltetrahydrofolate, in humans. Baggott JE; Tamura T Biochim Biophys Acta; 1999 Oct; 1472(1-2):323-32. PubMed ID: 10572954 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid. Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. Priest DG; Schmitz JC; Bunni MA; Stuart RK J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924 [TBL] [Abstract][Full Text] [Related]
16. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study. Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration. McGuire BW; Sia LL; Leese PT; Gutierrez ML; Stokstad EL Clin Pharm; 1988 Jan; 7(1):52-8. PubMed ID: 3257913 [TBL] [Abstract][Full Text] [Related]
18. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations. Bertrand R; Jolivet J J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408 [TBL] [Abstract][Full Text] [Related]
19. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts. Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289 [TBL] [Abstract][Full Text] [Related]
20. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells. Zhang ZG; Rustum YM Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]